Program Medical Microbiology Interdisciplinary Program, Graduate School, Chulalongkorn University Thesis The development of novel chimeric antigen receptor T cell targeting B7H3 for common solid cancers Year: 3
Qualification Master of Science (Medical Science) Title and Affiliation Cell and Gene therapy manufacturing center, King Chulalongkorn Memorial Hospital Brief Description of Research Interest Manufacturing cell and gene therapy...
Title and Affiliation Cellular Immunotherapy Research Unit, Chulalongkorn University, Deputy Director Cell and Gene therapy manufacturing center, King Chulalongkorn Memorial Hospital, Facility Director Link: https://www.research.chula.ac.th/researcher-/supannikar-tawinwung/
Qualification Master of Science (Biotechnology) Title and Affiliation Cellular Immunotherapy Research Unit Chulalongkorn University Brief Description of Research Interest CAR T cell research and development
Qualification Master of Science (Biotechnology) Title and Affiliation Cell and Gene therapy manufacturing center, King Chulalongkorn Memorial Hospital Brief Description of Research Interest Cell and gene therapy manufacturing process...
Qualification Master of Science (Pharmacology) Title and Affiliation Cellular Immunotherapy Research Unit Chulalongkorn University Brief Description of Research Interest CAR T cell research and development
Qualification Doctor of Pharmacy (Industrial Pharmacy) Title and Affiliation Cell and Gene therapy manufacturing center, King Chulalongkorn Memorial Hospital Brief Description of Research Interest Assurance of the manufacturing process...
Qualification Bachelor’s degree (Biochemistry) Title and Affiliation Cellular Immunotherapy Research Unit Chulalongkorn University Brief Description of Research Interest CAR T cell research and development Genome editing
Qualification Doctor of Philosophy in Science Research Topic Development of PD-L1 switch receptor T cells to improve the efficacy of CAR T cells
Research Topic Incorporating IL7Rα intracellular domain to enhance efficacy of B7H3-specific chimeric antigen receptor T cells against glioblastoma